Pyxis Oncology

Pyxis Oncology is a newly established company dedicated to the research and development of anti-cancer drugs. The company focuses on cancer immunotherapy, providing new treatment options for patients. Pyxis Oncology was founded by Dr. Thomas Gajewski, M.D., Ph.D., from the Ben-May Cancer Research Center at the University of Chicago, and has received support from the Polsky Center for Entrepreneurship and Innovation at the University of Chicago. The company has formed a world-class Scientific Advisory Board (SAB) composed of leading institutions in the fields of immunology and cancer research.